OpenAI launches GPT-Rosalind-6, a life sciences reasoning model for approved organizations only

OpenAI released GPT-Rosalind-6, a reasoning model for biology, drug discovery and translational medicine, offered as GPT-Rosalind-6 Research via trusted access to approved scientists, institutes, firms and government partners. It shares weights with GPT-6 Astra and refuses fewer dual-use biology queries but still refuses bioweaponization. It runs in Work and Codex; the API needs separate approval.

Why it matters

OpenAI is offering a flagship-level model with looser dual-use biology limits only to vetted organizations, a precedent for tiered access to frontier models in high-risk scientific fields.

Sources1

Written by dalao.ai: the title, summary and why it matters are our own words. The original reports are the record; their publishers keep authorship.